I was hoping for a bounce in Pfizer (PFE) that did not happen. Let’s sell a call on our uncovered shares to reduce our cost basis. Current Stock Price: $34.41 Cost Basis: $37.96 Action: Sell to open the PFE Feb Week Four (2/26) 35 Call for around $0.39 New Cost Basis: $37.57
Our Pfizer (PFE) Feb Week One (2/5) 38 Call is on track to expire worthless. I will recommend a new call to sell against shares next week. Current Stock Price: $34.95 Cost Basis: $37.96 Action: Watch call expire worthless
Pfizer (PFE) was unable to break through $37.50 this week and turned lower. The company is expected to announce earnings next week. I am recommending a call to sell on our uncovered shares in the hope that we will get called out around breakeven. Current Stock Price: $36.35 Cost Basis: $38.26 Action: Sell to open…
Our Pfizer (PFE) Jan Week Four (1/22) 37.50 Call is on track to expire worthless. I will recommend another call to sell soon to continue to reduce our net debit. Current Stock Price: $36.36 Cost Basis: $38.26 Action: Watch call expire worthless
Our Pfizer (PFE) Jan Week Four (1/22) 37.50 Call is on track to expire worthless. I will recommend another call to sell soon to continue to reduce our net debit. Current Stock Price: $36.36 Cost Basis: $38.26 Action: Watch call expire worthless
Pfizer (PFE) was unable to punch through $37.50 this week. I am recommending we sell a call at that level to bring in income and reduce our cost basis on the position. Current Stock Price: $36.80 Cost Basis: $38.65 Action: Sell to open the PFE Jan Week Four (1/22) 37.50 Call for around $0.39 New…
Our Pfizer (PFE) Jan Week Two (1/8) 40 Put is deep in the money, so I am recommending we accept shares. We will sell a call against them next week to reduce our cost basis. Current Stock Price: $37.33 Cash in Hand: $1.35 Action: Accept shares Cost Basis: $38.65
